MGUS Treatments

Below is a listing of treatments for monoclonal gammopathy of undertermined significance (MGUS) that are being tested in clinical trials around the US. We're here if you have questions or need help. Please call us today or create an account and we'll help you better understand your clinical trial options.

Create Your Account

Create your account today and get matched to myeloma treatments and trials around the US.

  • Find treatments with eligible clinical trials.
  • Get a second opinion from a myeloma specialist.
  • Receive alerts when new treatments become available.
  • Our services are always free for patients and HIPAA compliant.

Create Account

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

Daratumumab DARZALEX®

Daratumumab is a drug used for the treatment of multiple myeloma. It is for use in people who have multiple myeloma who have already received at least one prior therapy. It is given as an injection into a vein through an IV.

Learn more about this treatment

Monoclonal Antibody

Antibodies are cloned and used to attack one specific type of protein found in cancer cells.

Learn more about these treatments


Immunotherapy involves the use of many active agents such as cells, cytokines or vaccines (among others). These agents are used to induce, enhance or suppress the function of the immune system.

Learn more about these treatments